(2S,2S,Trans)-saxagliptin

CAS: 1564265-96-8

Ref. 3D-PMC26596

Produktinformation

• Name: (2S,2S,Trans)-saxagliptin

Beschreibung

(2S,2S,Trans)-saxagliptin is a drug product that has been developed as an oral anti-diabetic agent. It is a synthetic compound with the chemical name of (2S,2S,Trans)-4-[(1R)-1-[[(3Z)-3-(dimethylamino)-1-[(4-methylphenyl)sulfonyl]propanoyl]amino]-2-methylpropyl]-N-[4-(6-methoxy-3-pyridinyl)benzoyl]glycine. The synthesis of this drug is based on the natural amino acid sequence of the human insulin molecule. (2S,2S,Trans)-saxagliptin has been shown to be metabolized in vivo through hydroxylation and glucuronidation pathways and to have a half life of approximately 10 hours in humans. This drug product is intended for research and development purposes only

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 315.40 g/mol
• Formel: C₁₈H₂₅N₃O₂
• Reinheit: Min. 95%